Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer. (Q54223906)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer. |
scientific article |
Statements
Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer. (English)
Qi Yang
Yuan Shao
Jing Shi
Yiping Qu
Kexia Wu
Siwen Dang
Bingyin Shi
Peng Hou
1 January 2014
47
1-2
111-116